合并玻璃体积血的糖尿病视网膜病变患者的手术治疗分析  

Retrospective analysis of surgical treatments in 128 patients with proliferative diabetic retinopathy combined with vitreous hemorrhage

作　　者：周卓琳[1] 毕春潮[1] 王睿[1] 

机构地区：[1]中国陕西省西安市第四医院眼科,710004

出　　处：《国际眼科杂志》2013年第8期1648-1650,共3页International Eye Science

摘　　要：目的: 探讨合并玻璃体积血的增殖性糖尿病视网膜病变(proliferativediabeticretinopathy,PDR)的手术干预时机。方法: 采用回顾性的研究方法对128例177眼合并玻璃体积血的PDR患者的手术疗效进行对比观察。PDR患者依据疾病进程分为Ⅳ级组、Ⅴ级组以及Ⅵ级组。采用玻璃体切除术以及眼内视网膜激光对各组患者进行治疗,观察并比较三组患者手术并发症、前房炎症反应、术后1wk眼压以及术后6mo视力恢复情况。结果: 与术前相比,所有患者视力均恢复,但三组中以Ⅳ组视力恢复最为显著(P<0.05);三组患者手术相关并发症发生率、前房炎症以及术后平均眼压,均未发现统计学差异(P>0.05)。结论: 在Ⅳ级时对PDR患者进行手术干预可在不增加手术风险的同时显著提高疗效。·AIM： To explore the surgical intervention time in treatment of proliferative diabetic retinopathy （PDR） combined with vitreous hemorrhage. ·METHODS： Totally, 128 cases （177 eyes） with PDR combined with vitreous hemorrhage were investigated retrospectively. Patients with PDR were divided into IV group, V group and VI group. Vitrectomy and laser treatment were applied. Surgical complications, anterior chamber inflammation, intraocular pressure 1 week after surgeries and restoration of vision 6 months after surgeries were observed and compared between groups. ·RESULTS： Vision of all patients restored significantly after surgeries, but more significantly in IV group （P〈 0.05）; there were no significant differences of surgical complications, anterior chamber inflammation and intraocular pressure 1 week after surgeries in 3 groups （ P〉 0.05）. ·CONCLUSION： Clinical effects could be improved significantly by surgical intervention at IV stage of PDR without increasing any surgical risks.

关 键 词：糖尿病视网膜病变 玻璃体切割术 眼内激光治疗 

分 类 号：R779.6[医药卫生—眼科]